Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Sims

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Organic Chemistry|March 30, 2019
A Strategy toward Icetexane Natural ProductsDaniel J Moon, Mohammad Al-Amin, Robert S Lewis, et al.
Journal of Translational Medicine|March 8, 2022
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancersNicole J Toney, Lynn M Opdenaker, Kader Cicek, et al.
Materials Today. Bio|November 29, 2021
Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffoldsMarc Rabionet, Emma Polonio-Alcalá, Joana Relat, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Theranostics|June 28, 2012
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 PentetreotideEbrahim S Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, et al.
The American Journal of Tropical Medicine and Hygiene|August 11, 2007
Mechanisms of gene regulation in PlasmodiumKirk Deitsch, Manoj Duraisingh, Ron Dzikowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation responseJennifer Sims-Mourtada, Julie G Izzo, Smith Apisarnthanarax, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Mabs|February 9, 2016
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challengesKathryn Chapman, Akosua Adjei, Paul Baldrick, et al.
Genes & Development|November 5, 2025
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancerChunlei Shao, Alexandra Indeglia, Maya Foster, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Organic Chemistry|March 30, 2019
A Strategy toward Icetexane Natural ProductsDaniel J Moon, Mohammad Al-Amin, Robert S Lewis, et al.
Journal of Translational Medicine|March 8, 2022
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancersNicole J Toney, Lynn M Opdenaker, Kader Cicek, et al.
Materials Today. Bio|November 29, 2021
Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffoldsMarc Rabionet, Emma Polonio-Alcalá, Joana Relat, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumorsEbrahim S Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, et al.
Theranostics|June 28, 2012
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 PentetreotideEbrahim S Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, et al.
The American Journal of Tropical Medicine and Hygiene|August 11, 2007
Mechanisms of gene regulation in PlasmodiumKirk Deitsch, Manoj Duraisingh, Ron Dzikowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation responseJennifer Sims-Mourtada, Julie G Izzo, Smith Apisarnthanarax, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Mabs|February 9, 2016
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challengesKathryn Chapman, Akosua Adjei, Paul Baldrick, et al.
Genes & Development|November 5, 2025
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancerChunlei Shao, Alexandra Indeglia, Maya Foster, et al.
Pageof 6